Adamo Giorgia, Picciotto Sabrina, Gargano Paola, Paterna Angela, Raccosta Samuele, Rao Estella, Romancino Daniele Paolo, Ghersi Giulio, Manno Mauro, Salamone Monica, Bongiovanni Antonella
Cell-Tech HUB and Institute for Research and Biomedical Innovation (IRIB), National Research Council of Italy (CNR), Palermo, Italy.
Cell-Tech HUB and Institute of Biophysics (IBF), National Research Council of Italy (CNR), Palermo, Italy.
J Extracell Vesicles. 2025 Jan;14(1):e70030. doi: 10.1002/jev2.70030.
The application of extracellular vesicles (EVs) as therapeutics or nanocarriers in cell-free therapies necessitates meticulous evaluations of different features, including their identity, bioactivity, batch-to-batch reproducibility, and stability. Given the inherent heterogeneity in EV preparations, this assessment demands sensitive functional assays to provide key quality control metrics, complementing established methods to ensure that EV preparations meet the required functionality and quality standards. Here, we introduce the detectEV assay, an enzymatic-based approach for assessing EV luminal cargo bioactivity and membrane integrity. This method is fast, cost-effective, and quantifiable through enzymatic units. Utilizing microalgae-derived EVs, known as nanoalgosomes, as model systems, we optimised the assay parameters and validated its sensitivity and specificity in quantifying the enzymatic activity of esterases within the EV lumen while also evaluating EV membrane integrity. Compared to conventional methods that assess physicochemical features of EVs, our single-step analysis efficiently detects batch-to-batch variations by evaluating changes in luminal cargo bioactivity and integrity across various EV samples, including differences under distinct storage conditions and following diverse isolation and exogenous loading methods, all using small sample sizes. The detectEV assay's application to various human-derived EV types demonstrated its versatility and potential universality. Additionally, the assay effectively predicted EV functionality, such as the antioxidant activity of different nanoalgosome batches. Our findings underscore the detectEV assay's utility in comprehensive characterization of EV functionality and integrity, enhancing batch-to-batch reproducibility and facilitating their therapeutic applications.
将细胞外囊泡(EVs)用作无细胞疗法中的治疗剂或纳米载体,需要对其不同特性进行细致评估,包括其身份、生物活性、批次间的可重复性和稳定性。鉴于EV制剂固有的异质性,这种评估需要灵敏的功能测定法来提供关键的质量控制指标,以补充现有方法,确保EV制剂符合所需的功能和质量标准。在此,我们介绍了detectEV测定法,这是一种基于酶的方法,用于评估EV腔内货物的生物活性和膜完整性。该方法快速、经济高效,并且可以通过酶单位进行定量。我们利用微藻衍生的EVs(称为纳米藻体)作为模型系统,优化了测定参数,并验证了其在定量EV腔内酯酶的酶活性以及评估EV膜完整性方面的灵敏度和特异性。与评估EV物理化学特征的传统方法相比,我们的单步分析通过评估各种EV样品中腔内货物生物活性和完整性的变化,包括在不同储存条件下以及不同分离和外源加载方法后的差异,使用小样本量就能有效检测批次间的变化。detectEV测定法在各种人类来源的EV类型上的应用证明了其通用性和潜在的普遍性。此外,该测定法有效地预测了EV的功能,例如不同纳米藻体批次的抗氧化活性。我们的研究结果强调了detectEV测定法在全面表征EV功能和完整性、提高批次间可重复性以及促进其治疗应用方面的实用性。